Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-177-9 | CAS number: 5698-98-6
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guidline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Magnesium acrylate
- EC Number:
- 227-177-9
- EC Name:
- Magnesium acrylate
- Cas Number:
- 5698-98-6
- Molecular formula:
- C3H4O2.1/2Mg
- IUPAC Name:
- magnesium diacrylate
- Test material form:
- other: slightly brownish liquid
- Details on test material:
- Aqueous solution of magnesium acrylate,
pH: 6.4
Composition: 46.41% magnesium diacrylate
Purity (based on 100%): 99.7%
Production date: 18.11.2011
Expiry date: 18.05.2012
Storage: room temperature, keep away from light
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- nulliparous, non pregnant
TEST ANIMALS
- Source: TOXI-COOP ZRT, H-1103, Budapest, Cserkesz u. 90
- Age at study initiation: 8 -11 weeks
- Weight at study initiation: 15.7 -20.6 g
- Housing: 4 animals/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7 or 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+- 3
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- other: aqueous 1% Pluronic PE9200
- Concentration:
- - three groups received the Magnesium acrylate solution at 99%, 50% or 25%
- the negative control group received the vehicle (aqueous 1% Pluronic PE9200) only,
- the positive control received 25% alpha-Hexylcinnamaldehyde (HCA),
- the negative control group for the positive control group received aceton: olive oil 4:1 (v/v) - No. of animals per dose:
- four
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: some precipitation on the skin of the ear
- Irritation: no
- Lymph node proliferation response: no
On the basis of a pilot study a formulation of the test item with 1% Pluronic PE9200 was chosen so t
hat the test item was sufficiently applicable on the ears of the animals.
Each concentration was applied on the external surface of each ear (25 μl/ear) of the animals for three co
nsecutive days (day1, 2, 3).
There was no treatment on days 4, 5 and 6. On day 6, the cell proliferation in the local lymph nodes
was measured by determing incorporation of tritiated methyl thymidine and the obtained values were
used to calculate stimulation indices. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- Larger lymph nodes and a higher stimulation index than the control were observed in the positive control group.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: negative control: 1.0, positive control: 14.2, 99% test item: 0.7, 50% test item: 0.3, 25% test item: 0.9, negative control: 1.0
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: negative control: 619/node, positive control: 8790.9/node, 99% test item: 239.6/node, 50% test item: 107.9/node, 25% test item: 326.4/node, negative control: 344.8/node
- Parameter:
- SI
- Value:
- 0.7
- Test group / Remarks:
- test item conc. of 99%
- Parameter:
- SI
- Value:
- 0.3
- Test group / Remarks:
- test item conc. of 50%
- Parameter:
- SI
- Value:
- 0.9
- Test group / Remarks:
- test item conc. of 25%
Any other information on results incl. tables
No significant loss of body weight was observed in any treatment group.
No mortality, no obvious signs of systemic toxicity or irritation were observed in any treatment groups.
Loss of hair was observed in the 99% dose group from day1 to day 5.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- Under the conditions of the present Local Lymph Node Assay the magnesium acrylate solution of 46.41% content tested at the maximum attainable concentration of 99% and at concentrations of 50% and 25% as homogenous formulations in aqueous 1% Pluronic, was shown to have no
sensitization potential (non-sensitizer). - Executive summary:
A formulation of 46.41 % Magnesium acrylate in water was supplied by the sponsor for testing the sensitization potential. On the basis of a pilot study a formulation of the test item with 1% Pluronic PE9200 (w/v) was chosen so that the test item was sufficiently applicable on the ears of the animals. In the main assay 24 female CBA/Ca mice were allocated to six groups of four animals each:
- three groups received the Magnesium acrylate solution at 99%, 50% or 25% (v/v),
- the negative control group received the vehicle (aqueous 1% Pluronic PE9200) only,
- the positive control received 25% alpha-Hexylcinnamaldehyde (HCA),
- the negative control group for the positive control group received aceton: olive oil, 4:1 (v/v).
Each substance was applied on the external surface of each ear (25 µl/ear) of the animals for three consecutive days (day1, 2, 3). There was no treatment on days 4, 5 and 6. On day 6, the cell proliferation in the local lymph nodes was measured by determing incorporation of tritiated methyl thymidine and the obtained values were used to calculate stimulation indices:
negative control: 1.0,
positive control: 14.2,
99% test item: 0.7,
50% test item: 0.3,
25% test item: 0.9,
negative control: 1.0.
No significant loss of body weight was observed in any treatment group.
No mortality, no obvious signs of systemic toxicity or irritation were observed in any treatment groups.
Loss of hair was observed in the 99% dose group from day 1 to day 5.
Under the conditions of the present Local Lymph Node Assay the magnesium acrylate solution of 46.41% content tested at the maximum attainable concentration of 99% and at concentrations of 50% and 25% as homogenous formulations in aqueous 1% Pluronic PE9200, was shown to have no sensitization potential.
Thus magnesium acrylate is a non-sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
